Abstract-In an effort to verify the dose delivery in proton therapy, Positron Emission To mography (PET) scans have been employed to measure the distribution of /3+ radioactivity pro duced from nuclear reactions of the protons with native nuclei. Because the dose and PET distributions are not directly compara ble, the range verification is currently carried out by comparing measured and Monte Carlo (MC) simulation predicted PET distributions. In order to reduce the reliance on MC, MC-PET and dose distal endpoints were compared to explore the feasibility of using distal endpoints for in-room PET range verification. MC simulations were generated for six head and neck patients with corrections for radiological decay, biological washout, and PET resolution. One-dimensional profiles of the dose and MC-PET were examined along the direction of the beam and covering the cross section of the beam. The chosen endpoints of the MC-PET (y-intercept of the linear fit to the distal falloff) and MC dose (20-50% of maximum dose) correspond to where most of the protons are below the threshold energy for the nuclear reactions. The difference in endpoint range between the distal surfaces of the dose and MC-PET are compared and the spread of range differences are assessed. Among the six patients, the mean difference between MC-PET and dose depth was found to be -1.5 mm to +3.7 mm between patients, with a standard deviation of 1.3 to 6 mm across the individual beams.
. Fig. 1 shows an example of the shapes of dose, PET, and MC-PET profiles in a water phantom. The objective of this study is to explore the possibility of comparing directly the distal falloff points of the PET activation and the planned dose without the use of MC simulations. While the shape of activity profiles can be af fected by many factors (including elemental composition of tissues, nuclear reaction cross sections, biological washout of proton induced activity, etc.), in theory, the distal endpoint of an activity profile is only determined by the thresholds of nuclear reactions. The major benefit of this simplified new approach is that range verification would not rely on lengthy Monte Carlo calculations. As a proof of concept, the distal falloff of the planned dose was compared to a corresponding MC simulated PET activity falloff to determine if a simple, consistent relationship exists. Range inconsistencies in PET data collected from patients can eventually be used to improve treatment accuracy and detect errors in delivery.
II. METHODS

A. Range Comparison with Distal Endpoints
The direct range verification approach compares the end points of dose profiles and the corresponding PET activity profiles directly. Both profiles were generated for the lines of voxels along the beam path across the proton irradiation field.
The endpoints were determined separately for the dose and PET activity profiles to correspond roughly to the depth where very few protons are above the threshold energy for the nuclear interactions creating the PET signal. In proton therapy, PET The PET endpoint was set as the y-intercept of the best linear fit to the distal falloff region. A fit was chosen to avoid uncertainties in local variations that can affect ranges that are based on a percentage of the distal maximum. Also, the fit uses information from multiple points in the falloff curve, rather than a single point. Other functions were explored for the distal fit, but the linear extrapolation is reasonable, quick, and gives a clear indication of the end of activation. The linear fit was found to be the most consistent and independent of specific dose delivery conditions. To avoid variations in endpoint deter mination caused by the shapes of PET activity profiles, all the profiles were standardized before the linear fit was performed.
First, a reverse biological washout correction was applied to the PET data according to CT number determined tissue types and a biological washout model [3] , [4] . Then the amplitude of activity level at each voxel was scaled against the local 1 6 0 (target of the nuclear reaction channel of interest) elemental density, again determined by the CT numbers. Finally the depth axis of the profile was expanded/contracted to water equivalent thickness by interpolation. In theory, the adjusted profiles should all have a shape similar to what would be produced in a homogeneous water volume.
The dose endpoint was chosen to be in the middle of the range between 50% and 20% of the profile maximum. For most dose profiles with steep falloffs, the 20% 50% distance is small, but for those with gentler slopes, often arising from air pockets or lateral he terogeneities, including the 20% point captures those protons that "punch through" or move laterally [5] and are still energetic enough to create PET isotopes. To be consistent with the PET activity profile standardization, the depth axis of the dose profile was also stretched to water-equivalent thickness before the endpoint was determined.
The range difference between dose and PET was calculated by subtracting the dose endpoint from the PET endpoint. A positive number indicates overshoot while a negative number indicates undershoot. The smaller the absolute difference, the more likely the dose was delivered as planned. The dose and PET endpoints were calculated and compared for each modulation.
Because the chosen dose endpoint does not correspond ex actly with the PET endpoint, corrections have to be determined for the expected difference between the PET endpoint from the linear fit and that of the dose at 20-50% of the maximum. The MC simulations above were also used to determine the bias between these two endpoints for different modulations.
C. Patient Me Simulation Study
MC studies were conducted to evaluate the feasibility of the direct range comparison method. PET simulations were generated for six head and neck cancer patients using the Geant4 Monte Carlo system [6] . 
E. MC Simulation
A Geant4-based Monte Carlo system developed at MGH was used for all the simulations [6] . The system was im plemented with the design of the proton delivery system at the Burr Proton Center at MGH [7] . A total of 4xl0 7
protons from the treatment nozzle were simulated using the planning information, i.e., proton energy (range), modulation, range compensation, and aperture shape. The protons were then simulated to interact with the materials in the head based on the CT scan of the patient. The HU numbers were converted to densities and elemental compositions according to [8] . Each set of protons was used on the CT grid 40 times with different randomizations to improve the statistics.
Since the nuclear interactions that produce the PET activity are very rare, the number of activated isotopes was calculated by combining the proton energy in each voxel with energy dependent nuclear cross section data obtained and optimized elsewhere [9 ] . The number of isotopes created was then scaled based on the expected number of protons delivered. The five most abundant PET isotopes produced from eight reaction channels, as listed in Ta ble I, were included in our simulations.
After simulations, radiologic decay of isotopes and biologic washout were applied according to typical in-room irradiation length (30 to 90 seconds), delay time between irradiation and scanning (90 to 150 seconds), and scan duration (5 minutes).
Biological washout parameters were based on those in [3] , [4] . The MC-PET was smoothed to a PET resolution of 7 mm FWHM with a Gaussian kernel. The simulation at this point mimicked data from a PET scanner. 
III. RESULTS
A. Modulation-Dependence of Endpoints
C. Animal Study Results
For the rabbit thigh we found a mean PET to dose difference of 1.2 mm with a standard deviation of 2.8 mm. For this method to be useful with PET data, there must be excellent co-registration accuracy between the PET activity, treatment plan dose, and the CT used for attenuation and heterogeneity corrections. An integrated mobile NeuroPET/CT currently in development will provide sufficient co-registration accuracy and in-room capabilities to apply this method to PET data.
In this feasibility study we also assumed that a reasonable biological washout model is available so that all the activity profiles can be standardized to similar shapes. However, the washout model used by the proton community right now was adopted from carbon beam studies [4] and its applicability to proton therapy is questionable. A more accurate washout model specifically for proton induced PET activity is very desirable. We are currently developing a new kinetic modeling approach to estimate the 150 production map from dynamic PET data directly. This approach, if successful, is expected to greatly improve the performance of the direct range compari son, as no reverse washout correction would be necessary.
If PET range verification is to be used routinely in clinics, this simplified approach can be used as an expeditious screen ing method to filter out cases in need of more time-consuming
Monte Carlo analysis. Plotting the distal surface difference between PET and dose presents a quick view of areas where the dose "undershoots" or "overshoots" the desired location.
Those areas around sensitive locations, or with less than full coverage of the tumor, can then be addressed in more detail.
V. CONCLUSIONS
We developed a simplified approach for proton range ver ification with PET by comparing the dose and PET activity endpoints directly, and validated our methods with MC sim ulated patient studies. The new method can be used as an expeditious screening method to filter out cases in need of more time-consuming Monte Carlo analysis.
